Zdrowie i gospodarka · 10/08/2010
NIH to Grant Exclusive License for HIV and HCV Treatment
The National Institutes of Health (NIH) is considering granting an exclusive license to practice inventions related to Griffithsin, a potential biotherapeutic for treating HIV and HCV infections, as outlined in two provisional patent applications filed by Dr. Barry O'Keefe and colleagues.